Inventiva (IVA) Change in Receivables (2019 - 2025)
Inventiva (IVA) posted quarterly Change in Receivables of -$16.4 million for Q2 2025, down 307.65% quarter-over-quarter from -$4.0 million in Q4 2022.
Powered by 
Analysis
Inventiva (IVA) Change in Receivables (2019 - 2025) Analysis & Trends
Inventiva's Change in Receivables history runs 5 years deep, the most recent figure standing at -$16.4 million for Q2 2025.
- In Q2 2025, Change in Receivables changed N/A year-over-year to -$16.4 million; the TTM figure through Jun 2025 stood at -$16.4 million (changed N/A YoY), while the FY2025 annual figure was $989437.0, down 67.0% from the prior year.
- Change in Receivables for Q2 2025 stood at -$16.4 million, down from -$4.0 million in the prior quarter.
- The five-year high for Change in Receivables was $4.1 million in Q3 2022, with the low at -$16.4 million in Q2 2025.
- The 3-year median for Change in Receivables is -$133428.9 (2021), against an average of -$2.8 million.
- The sharpest annual moves came in 2021 and 2022: Change in Receivables soared 132.11% in 2021, then tumbled 4718.42% in 2022.
- Inventiva's Change in Receivables stood at -$83509.9 in 2021, then sank by 4718.42% to -$4.0 million in 2022, then tumbled by 307.65% to -$16.4 million in 2025.
- Business Quant data shows IVA's Change in Receivables at -$16.4 million in Q2 2025, -$4.0 million in Q4 2022, and $4.1 million in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -16.40 Mn |
| Dec 31, 2022 | -4.02 Mn |
| Sep 22, 2022 | 4.06 Mn |
| Dec 31, 2021 | -83,509.88 |
| Jun 30, 2021 | 95,137.44 |
| Mar 31, 2021 | -183,347.89 |
| Dec 31, 2020 | -482,877.39 |
| Jun 30, 2020 | -296,292.77 |
| Mar 31, 2020 | -150,135.71 |
| Dec 31, 2019 | 1.81 Mn |